Albumedix, now part of Sartorius, is a science-driven company and recognized leader of best-in-class albumin-enabled solutions. Established in the UK in 1984, with a mission to empower excellence, Albumedix has supported its life-science partners to deliver hundreds of million safe doses of clinical and marketed therapeutics, globally. Albumedix’ solutions include the world’s only USP-NF compliant recombinant human albumin (Recombumin®), client-centric development and compliance services and drug-enhancing technologies (Veltis®). By always striving for more and collaboratively challenging status quo, Albumedix enables the development and commercialisation of advanced therapies and next-generation biopharmaceuticals to the benefit of people worldwide.
External link for Albumedix now a part of Sartorius
Mabel Street
Albumedix
Nottingham, NG2 3ED, GB
Albumedix now a part of Sartorius reposted this
Last day to register for our webinar to learn how to optimize lentiviral vector production with high-throughput bioreactors and next-generation transfection reagents. Click the link to register - https://sar.to/z6i6g #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy
Albumedix now a part of Sartorius reposted this
Sign up for our upcoming webinar to learn how to optimize lentiviral vector production with high-throughput bioreactors and next-generation transfection reagents. Click the link to register: https://sar.to/z6i6g #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy
Last week, Sartorius proudly participated in Hanson Wade Group’s inaugural Raw Materials for Cell and Gene Therapy Summit as the Expertise Partner. Together with therapy developers, supply chain, quality and regulatory leaders, we engaged in dynamic discussions on quality and regulatory considerations surrounding ancillary materials, starting materials, and single-use components in CGT manufacturing. Sartorius is actively involved in shaping regulatory guidelines for CGT raw materials. Visit our website to learn more about our highest-quality critical raw materials for CGT with extensive regulatory support and request your sample today! https://lnkd.in/dGzuBhYw Scroll through the tiles below for some of our key takeaways:
Albumedix now a part of Sartorius reposted this
Sartorius, through its subgroup Sartorius Stedim Biotech, today opened its new Center for Bioprocess Innovation in Marlborough, #Massachusetts. 🎉👏 The facility is designed to foster collaboration, co-development and learning on site with customers and other #innovation partners, applying Sartorius' latest technologies in real-life bioprocess workflows. 💬 "Cell and gene therapies and other novel treatments offer promising solutions for patients with previously incurable diseases. However, these modalities are still in their infancy and often require the development of new manufacturing processes. This cutting-edge innovation center enables us to accelerate and simplify our customers’ path to clinical trials," said René Fáber, CEO of Sartorius Stedim Biotech. Key features include: ➡️ New research labs and process development services to enable next generation therapeutics ➡️Up- and downstream process optimization, proof of concept runs, demos and trainings for customers ➡️Coming 2025: two GMP suites for implementing novel manufacturing processes 🔗 Read media release: https://lnkd.in/emff6U-7 🤝 Massachusetts Executive Office of Economic Development (EOED) | Marlborough Economic Development Corporation | CITY OF MARLBOROUGH | Massachusetts Life Sciences Center | MassBio | Maurice Phelan #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy
Check out this on-demand webinar to see how our chemically-defined biopreservation solutions can help the stability and post-thaw recovery of your cell therapies! Click the link to watch the webinar and learn more! https://lnkd.in/eXAPQZnF #celltherapy #cryopreservation #coldstorage #biopreservation #preclinical #safety #animalcomponentfree
We are excited to join the inaugural Raw Materials for Cell & Gene Therapy Summit as the Expertise Partner! Our very own Phil Morton, CTO of Sartorius Albumedix, will deliver a talk titled “Worth the Switch? Exploring a Chemically-Defined Raw Material Strategy for Your Cell Therapy Manufacturing.” We look forward to engaging in conversations on supplier selection, material quality, safety assurance, and the good manufacturing practices required to develop regulatory-compliant and high-quality cell and gene therapies. #cellandgenetherapy #rawmaterials #chemicallydefined #advancedtherapysolutions
🎃 Don’t get spooked by quality and regulatory requirements! 👻 It’s your last chance to register for tomorrow’s webinar on decoding raw material quality and regulatory standards in cell and gene therapy 🧬. Join us for an insightful session that will be a real treat this Halloween! 🍬 Click the link to join - https://lnkd.in/dvDZMSnf
Join our webinar to learn how to increase viral genome 15-fold with an upstream #AAV platform powered by next-gen raw materials. Register via the link below. https://sar.to/ceycd #SimplifyingProgress #InThisTogether #CellandGeneTherapy #AdvancedTherapies #CellTherapy #GeneTherapy
Meet us at #ESCGT24 Sartorius booth #5,6 and 8 to discover our products and solution in Advanced Therapy Solution
We’re back #FromTheFloor at #ESGCT24 with Enzo from Sartorius to hear about what they’re presenting at this year’s congress!